‘When a pharmaceutical manufacturer markets the identical product in EU member state A under trade mark X and in EU member state B under trade mark Y, in what circumstances can a parallel importer take the goods (marked X) from state A to state B and re-brand them with mark Y? ‘
Arden, Floyd, Bean LJ
[2015] EWCA Civ 54
Bailii
England and Wales
Intellectual Property, European
Updated: 27 December 2021; Ref: scu.542304